Market Research Report

A quick peek into the report

Global Autoimmune Disorder Drug Delivery Devices Market

Focus on Product Type, Indication, Manufacturing Type, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030

Some Faq's

Frequently Asked Questions

Answer – From a market value of $1.69 billion in 2019, the global market for autoimmune disorder drug delivery devices is estimated to reach the mark of $10.67 billion by the end of 2030.

Answer – Factors such as the increased prevalence of autoimmune disorders, technological advancements in the field of pre-filled syringes, rising geriatric population, and the surge of biosimilars and biologics in the pharmaceutical market, influence the growth curve of the global autoimmune disorder drug delivery devices market

Answer – The exponential rise in the adoption of self-injection devices for the treatment of autoimmune disorders has created a buss among companies to invest in the development of novel autoimmune disorder drug delivery devices.

Answer – Based on region, the North American region dominates the global market due to its improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions.

Answer – Prominent market players involved include Amgen Inc., AbbVie Inc., Bayer AG, Biogen Inc., Eli Lilly & Company, GSK PLC, Merck KGaA, and Teva Pharmaceutical Industries Ltd., among others.

Similar Product

You may also like

Global Injectable Drug Delivery Market
Published Year: 2018

Global Injectable Drug Delivery Market : Focus on Devices, Competitive Landscape and Country - Analy

The global injectable drug delivery market was estimated at $16.73 billion in 2016 and is...